Hongene Biotech
Hongene Biotech, a leading supplier of nucleic-acid chemistry, co-authored the improved P(V) thio-oligonucleotide synthesis platform.
Union City, California and Shanghai, China
Hongene Biotech
- Papers together
- 1
- Years
- 2025
- Co-authors
- 3
The record
Our paper with Hongene Biotech
-
An Improved P(V) Thio-Oligonucleotide Synthesis Platform
- Elsie Biotechnologies Kyle W. Knouse, Richard L. Redman, Yonghao Jin
- Hongene Biotech David Butler, Yang Yang, Yao Feng
- Socrates Biosciences Arjun Natarajan
No papers match these filters.
Our co-authors at Hongene Biotech
David Butler · Yao Feng · Yang Yang
Some of these papers were shared with 2 other partners: Elsie Biotechnologies, Socrates Biosciences.
Keep exploring
More partners
Enamine
HitGen IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Work with us
Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu